Elsevier

The Lancet

Volume 345, Issue 8965, 24 June 1995, Pages 1600-1603
The Lancet

Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease

https://doi.org/10.1016/S0140-6736(95)90115-9Get rights and content

Abstract

Several genes, including some encoding components of the renin angiotensin system, are associated with the risk of cardiovascular diseases. There have been reports linking a homozygous deletion allele of the angiotensin converting enzyme (ACE) gene (DD) with an increased risk of myocardial infarction, and some variants of the angiotensinogen gene with an increased risk of hypertension. In a case-control study of a caucasian population from New Zealand, we examined the associations with coronary heart disease (CHD) of ACE DD and of a mis-sense mutation with methionine to threonine aminoacid substitution at codon 235 in the angiotensinogen gene (T235). We studied 422 patients (mean age 62 years, 81% male) with documented CHD (50% with myocardial infarction) and 406 controls without known CHD (frequency-matched to cases by age and sex). Risk factors for CHD were assessed by standard questionnaire, physical examination, and blood tests. Genomic DNA from leucocytes was analysed for various ACE and angiotensinogen alleles. Angiotensinogen T235 homozygotes were at significantly increased risk of CHD generally (odds ratio 1·7, 2p=0·008) and of myocardial infarction specifically (1·8, 2p=0·009). Adjustment for several risk factors increased the estimate of CHD risk associated with this allele to 2·6 (2p<0·001) and the estimate for myocardial infarction risk to 3·4 (2p<0·001). By contrast, there was no evidence of a significant increase in the risk of CHD or myocardial infarction among individuals with ACE DD. We conclude that the T235 polymorphism of the angiotensinogen gene is an independent risk factor, which carries an approximately two-fold increased risk of CHD. In this study, however, ACE DD was not associated with any detectable increase in CHD risk.

References (26)

  • M. Bohn et al.

    Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction

    Clin Genet

    (1993)
  • K. Lindpaintner et al.

    Angiotensin converting enzyme (ACE) genotype and risk of myocardial infarction (MI)

    Clin Res

    (1993)
  • Cited by (325)

    • Angiotensinogen: More Than its Downstream Products: Evidence From Population Studies and Novel Therapeutics

      2022, JACC: Heart Failure
      Citation Excerpt :

      For these reasons, genetic association studies between angiotensinogen single-nucleotide polymorphisms (SNPs) and CVD have been the primary means of investigation in population studies.8,53,54 The key SNPs that have been repeatedly found to have an association with CVD in large scale studies are SNP M235T or (reference SNP ID rs699), SNP T174M (or rs4762), and SNP G(-6)A (or rs5051) (Figure 5, Table 1).8-10,17 SNP M235T (rs699) is a missense variant that has been associated with an increase in angiotensinogen plasma concentration,55,56 an increased incidence of hypertension,10,57,58 and higher mortality related to heart failure.60-63

    • Angiotensinogen and angiotensins

      2018, Encyclopedia of Endocrine Diseases
    • Association of angiotensin-converting enzyme polymorphism with coronary artery disease in Iranian patients with unipolar depression

      2012, Clinical Biochemistry
      Citation Excerpt :

      Statistical analysis of the mentioned SNPs on the ACE and AGT genes individually also showed no association with CAD in depressed patients. Several studies have reported association of AGT M235T polymorphism with CAD [42,43] while a meta-analysis, including twelve studies, has demonstrated no association in this regard [69]. Thus, the lack of relationship between AGT M235T polymorphism and CAD in depressed Iranian individuals is consistent with the results reported by some other studies carried out in low risk populations.

    • Polymorphisms of angiotensin II type 1 receptor gene and those of angiotensinogen point at culprit artery in ST-segment elevation myocardial infarction

      2012, Gene
      Citation Excerpt :

      Results are presented in Table 1. In patients with diagnosed coronary artery disease, RAS gene polymorphisms were examined mainly in terms of the risk for coronary artery disease or acute MI (Katsuya et al., 1995; Tiret et al., 1994). Nakauchi et al. found that the number of affected vessels was significantly greater in patients with the AC genotype for AGTR1 1166A/C gene polymorphism than in those with the AA genotype (1.93 vs 1.27, p < 0.05) (Nakauchi et al., 1996).

    View all citing articles on Scopus
    View full text